Index | MSCI UK (EUR Hedged) |
Investment focus | Equity, United Kingdom |
Fund size | GBP 4 m |
Total expense ratio | 0.23% p.a. |
Replication | Physical (Full replication) |
Legal structure | ETF |
Strategy risk | Long-only |
Sustainability | No |
Fund currency | EUR |
Currency risk | Currency hedged |
Volatility 1 year (in GBP) | 10.86% |
Inception/ Listing Date | 15 November 2023 |
Distribution policy | Distributing |
Distribution frequency | At least annually |
Fund domicile | Luxembourg |
Fund Provider | UBS ETF |
Fund Structure | Company With Variable Capital (SICAV) |
UCITS compliance | Yes |
Administrator | State Street Bank International GmbH, Luxembourg Branch |
Investment Advisor | |
Custodian Bank | State Street Bank International GmbH, Luxembourg Branch |
Revision Company | Ernst & Young, société anonyme |
Fiscal Year End | 31 December |
Swiss representative | UBS Fund Management (Switzerland) AG |
Swiss paying agent | UBS Switzerland AG |
Germany | Unknown |
Switzerland | ESTV Reporting |
Austria | Tax Reporting Fund |
UK | UK Reporting |
Indextype | - |
Swap counterparty | - |
Collateral manager | |
Securities lending | Yes |
Securities lending counterparty | ABN AMRO Bank N.V.|Bank of Nova Scotia (London Branch)|Barclays Bank plc|Barclays Capital Securities Limited|BNP Paribas (London Branch)|BNP Paribas SA|Citigroup Global Markets Limited|Commerzbank AG|Commerzbank AG (London Branch)|Credit Suisse Securities (Europe) Limited|Deutsche Bank AG|Deutsche Bank AG (London Branch)|Goldman Sachs International|HSBC Bank plc|ING Bank N.V.|ING Bank N.V. (London Branch)|JP Morgan Securities PLC|MacQuarie Bank Ltd. (London Branch)|Merrill Lynch International|Morgan Stanley Morgan Stanley & Co. International plc|SEB AG (Frankfurt Branch)|Skandinaviska Enskilda Banken|Societe Generale SA|Societe Generale SA (London Branch)|State Street Bank International GmbH (London Branch) |
AstraZeneca PLC | 8.81% |
Shell Plc | 8.36% |
HSBC Holdings Plc | 6.79% |
Unilever Plc | 6.07% |
RELX | 3.42% |
BP Plc | 3.21% |
GSK Plc | 2.97% |
Rio Tinto Plc | 2.91% |
British American Tobacco plc | 2.77% |
Diageo Plc | 2.75% |
United Kingdom | 90.92% |
Switzerland | 2.48% |
Ireland | 2.04% |
Other | 4.56% |
Financials | 18.63% |
Consumer Staples | 17.86% |
Industrials | 13.06% |
Health Care | 12.38% |
Other | 38.07% |
YTD | +4.54% |
1 month | +0.98% |
3 months | -2.37% |
6 months | -0.34% |
1 year | +9.41% |
3 years | - |
5 years | - |
Since inception (MAX) | +7.74% |
2023 | - |
2022 | - |
2021 | - |
2020 | - |
Current dividend yield | 2.51% |
Dividends (last 12 months) | GBP 0.05 |
Period | Dividend in GBP | Dividend yield in % |
---|---|---|
1 Year | GBP 0.05 | 2.66% |
Volatility 1 year | 10.86% |
Volatility 3 years | - |
Volatility 5 years | - |
Return per risk 1 year | 0.86 |
Return per risk 3 years | - |
Return per risk 5 years | - |
Maximum drawdown 1 year | -7.67% |
Maximum drawdown 3 years | - |
Maximum drawdown 5 years | - |
Maximum drawdown since inception | -7.67% |
Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
---|---|---|---|---|---|
XETRA | EUR | CHSC | CHSC GY CHSCEUIV | CHSC.DE CHSCEURINAV=SOLA |
Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
---|---|---|---|---|
iShares Core FTSE 100 UCITS ETF (Dist) | 13,591 | 0.07% p.a. | Distributing | Full replication |
Vanguard FTSE 100 UCITS ETF Distributing | 4,434 | 0.09% p.a. | Distributing | Full replication |
iShares Core FTSE 100 UCITS ETF GBP (Acc) | 2,670 | 0.07% p.a. | Accumulating | Full replication |
Vanguard FTSE 250 UCITS ETF Distributing | 2,465 | 0.10% p.a. | Distributing | Full replication |
Vanguard FTSE 100 UCITS ETF (GBP) Accumulating | 1,664 | 0.09% p.a. | Accumulating | Full replication |